
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152552A58AF43D430552A5001238837C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmccanc">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Cancer">
<meta name="citation_title" content="Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study">
<meta name="citation_author" content="Weibin Lian">
<meta name="citation_author_institution" content="Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China">
<meta name="citation_author" content="Liangqiang Li">
<meta name="citation_author_institution" content="Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China">
<meta name="citation_author" content="Chengye Hong">
<meta name="citation_author_institution" content="Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China">
<meta name="citation_author" content="Debo Chen">
<meta name="citation_author_institution" content="Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="1331">
<meta name="citation_doi" content="10.1186/s12885-025-14774-w">
<meta name="citation_pmid" content="40826347">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/pdf/12885_2025_Article_14774.pdf">
<meta name="description" content="The impact of adjuvant ovarian function suppression (OFS) in premenopausal patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-positive (HER2+) breast cancer remains unclear. The study aims to evaluate the ...">
<meta name="og:title" content="Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The impact of adjuvant ovarian function suppression (OFS) in premenopausal patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-positive (HER2+) breast cancer remains unclear. The study aims to evaluate the ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12359915">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12885-025-14774-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12885_2025_Article_14774.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12359915%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12359915/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12359915/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmccanc.png" alt="BMC Cancer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Cancer" title="Link to BMC Cancer" shape="default" href="https://doi.org/10.1186/s12885-025-14774-w" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Cancer</button></div>. 2025 Aug 18;25:1331. doi: <a href="https://doi.org/10.1186/s12885-025-14774-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12885-025-14774-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Cancer%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Cancer%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Impact of ovarian function suppression on prognosis in premenopausal patients with HR+/HER2 + early-stage breast cancer: a multi-center retrospective study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lian%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Weibin Lian</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Weibin Lian</span></h3>
<div class="p">
<sup>1</sup>Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lian%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weibin Lian</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Liangqiang Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Liangqiang Li</span></h3>
<div class="p">
<sup>1</sup>Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liangqiang Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hong%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chengye Hong</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chengye Hong</span></h3>
<div class="p">
<sup>1</sup>Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hong%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chengye Hong</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Debo Chen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Debo Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Debo Chen</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, Fujian 362000 P.R. China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Sep 23; Accepted 2025 Jul 29; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12359915  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40826347/" class="usa-link">40826347</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">The impact of adjuvant ovarian function suppression (OFS) in premenopausal patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-positive (HER2+) breast cancer remains unclear. The study aims to evaluate the value of OFS for patients with HR+/HER2 + early-stage breast cancer treated with trastuzumab.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">Kaplan-Meier curves and the log-rank test were used to compare disease-free survival (DFS). Univariate and multivariate Cox regression analyses were performed to identify significant prognostic factors. Multivariable logistic regression model was used to predict the utilization of OFS.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">A total of 1,338 patients from multiple centers were enrolled, including 570 who received OFS treatment. Patients treated with selective estrogen receptor modulators (SERM) or aromatase inhibitors (AI) plus OFS as adjuvant endocrine therapy showed significantly better DFS compared to those who received SERM alone (HR = 0.496; 95% CI: 0.307–0.803; <em>p</em> = 0.004). Univariate and multivariate Cox regression analysis further confirmed that receiving SERM/AI plus OFS as adjuvant endocrine therapy was an independent prognostic factor in HR+/HER2 + early-stage breast cancer patients. Subgroup analysis indicated that patients with estrogen-receptor (ER) expression below 50%, histological grade 3, tumors larger than 2 cm, or lymph node-positive could benefit from OFS. In addition, age&lt;35 years, nodal involvement, histological grade 3 and ER expression below 50% were more likely to receive OFS compared with control group.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">Our study confirms that premenopausal patients with HR+/HER2 + early-stage breast cancer could benefit from additional OFS after trastuzumab treatment.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Breast cancer, Premenopausal, Prognostic, Ovarian function suppression, HR+/HER2+</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par5">The age of breast cancer diagnosis in China is generally 10 years younger than that in Western populations, with more than 60% of patients being premenopausal [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. As is known, approximately 80% of early-stage breast cancers are hormone receptor-positive (HR+) subtype and require adjuvant endocrine therapy [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. In the past 20 years, tamoxifen has been the standard endocrine therapy for premenopausal breast cancer [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Results from the phase III clinical trial (SOFT) indicated that tamoxifen plus ovarian function suppression (OFS) significantly improves the survival of HR-positive breast cancer compared to tamoxifen alone [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Subgroup analysis suggested that human epidermal growth factor receptor 2 (HER2) status does not affect the benefits from OFS. The ASTRRA trial, which included younger patients (under the age of 45), similarly demonstrated that an additional two years of OFS can further reduce the recurrence risk of HR + breast cancer [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. However, subgroup analysis from the ASTRRA trial revealed that the benefit of OFS was primarily observed in the HR-positive, HER2-negative subtype (HR+/HER2-), but not in HR+/HER2 + tumors. Moreover, few patients with the HR+/HER2 + subtype were enrolled in these two trials. Therefore, the survival benefit of OFS for HR+/HER2 + BC remains controversial.</p>
<p id="Par6">
Endocrine therapy is the most important treatment for the HR + HER2- subtype. The SOFT trial suggested that tamoxifen plus OFS improves outcomes compared to tamoxifen alone in HR + HER2- patients who are at sufficient risk to warrant adjuvant chemotherapy [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. According to the result from Monarch E trial, patients with HR+/HER2-, node-positive early-stage BC who are at high risk of recurrence could benefit from abemaciclib [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Few studies focus on the endocrine therapy of the HR+/HER2 + subtype. However, due to the complex interaction between the estrogen receptor (ER) and HER2 signaling pathways, HR+/HER2 + subtypes exhibit different responses to endocrine therapy [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. An increasing body of research indicates that HR + early breast cancer patients with HER2-positive tumors benefit less from tamoxifen compared to those with HER2-negative tumors and have an increased risk of tamoxifen treatment failure [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Multiple studies have shown that anti-HER2 therapy significantly improves invasive disease-free survival rates among patients with HER2-positive breast cancer [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. However, only a few HR+/HER2 + patients enrolled in the SOFT trial received trastuzumab treatment. It remains unknown whether HR+/HER2 + breast cancer patients can benefit from additional OFS after trastuzumab treatment.</p>
<p id="Par7">Regan et al. developed a composite scoring model using the nonparametrics sliding-window subpopulation treatment effect pattern plot(STEEP)methodology based on data from the SOFT and TEXT trials to help clinicians identify high-risk HR+/HER2- BC patients [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. OFS is recommended for HR+/HER2- patients with a high recurrence score. However, there is currently no suitable approach to guide the application of OFS for HR+/HER2 + breast cancer. In this study, we aimed to report real-world treatment patterns pertaining to the choice of adjuvant endocrine therapy and evaluate the value of OFS for HR+/HER2 + breast cancer patients who have received trastuzumab treatment.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Patients and study design</h3>
<p id="Par8">We included premenopausal women with HR+/HER2 + early-stage breast cancer diagnosed between January 1, 2012, and December 31, 2021. Clinicopathologic features were obtained from the Shanghai Jiaotong University-Breast Cancer Database (SJTU-BCDB), which includes data from 42 breast centers in China. The study protocol received approval from the independent ethical committee of Quanzhou First Hospital, affiliated with Fujian Medical University, and adhered to the principles of the Helsinki Declaration. A waiver of informed consent was granted due to the retrospective nature of the study.</p>
<p id="Par9">All patients received trastuzumab, administered as a loading dose of 8 mg/kg followed by a maintenance dose of 6 mg/kg, or along with pertuzumab (recommended for patients with positive lymph nodes, loading dose of 840 mg on cycle 1 and 420 mg thereafter every three weeks). Neoadjuvant therapy was recommended for patients with tumors larger than 2 cm or with lymph node metastasis. Patients with non-pathological complete remission (non-pCR) after receiving neoadjuvant therapy are recommended to use trastuzumab emtansine (T-DM1). The neoadjuvant or adjuvant chemotherapy regimens utilized in this study included: 1.EC-T regimen: Epirubicin (100 mg/m²) and cyclophosphamide (600 mg/m²) administered every three weeks for four cycles, followed by docetaxel (80 mg/m²) every three weeks for four cycles; 2. TCb regimen: Docetaxel (75 mg/m²) and carboplatin (area under the curve [AUC] = 6) administered every three weeks for six cycles; 3. TC regimen: Docetaxel (75 mg/m²) and cyclophosphamide (600 mg/m²) administered every three weeks for four cycles; 4.wP regimen: paclitaxel (80 mg/m²) every weeks for 12 cycles. Chemotherapy and Anti-HER2 targeted therapy are administered simultaneously, except when combined with anthracyclines. The decision to apply OFS for treatment follows institutional guidelines based on risk stratification and tumor biological characteristics, and is determined through discussions among departmental physicians.</p>
<p id="Par10">In this study, all patients received at least 2 years of SERM or SERM/AI combined with OFS treatment. We excluded male breast cancer patients and those with a history of breast cancer or other invasive cancers. Patients with stage 0 or IV disease were also excluded. In additon, patients lacking information on endocrine therapy and follow-up were excluded from our study. Based on our power analysis conducted prior to study initiation, we targeted enrollment of 1,300-1,350 patients to achieve adequate statistical power for detecting a clinically meaningful difference in the primary endpoint between treatment groups. This sample size calculation accounted for an anticipated 10% attrition rate and allowed for subgroup analyses of the different endocrine therapy regimens.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Definition</h3>
<p id="Par11">
The primary endpoint of our study is disease-free survival (DFS), defined as the time from the date of receiving neoadjuvant chemotherapy (NAC) to the occurrence of recurrence, metastasis, or death. All patients undergo outpatient follow-up visits, including every three months during the first two years after surgery, every six months during years 3–5, and annually after the fifth year. Follow-up includes medical history review, physical examination, corresponding tumor marker tests, and imaging studies. In addition, we regularly assess patients’ presenting symptoms and communicate with patients to raise their awareness about signs of recurrence.</p>
<p id="Par12">ER or progesterone receptor (PR) positivity was defined as having at least 1% staining in tumor nuclei. ER or PR was categorized as low expression (&lt; 50%) or high expression (≥ 50%). HER2 positivity was determined by immunohistochemistry (IHC) with a score of 3+ (IHC+++) or a score of 2+ (IHC++) confirmed by positive fluorescent in situ hybridization (FISH). Ki-67 index was categorized as low expression (&lt; 30%), or high expression (≥ 30%). These biomarkers evaluation was primarily based on the assessment of surgical specimens using standardized immunohistochemistry protocols. In cases where neoadjuvant therapy was administered, biomarker status was determined from the preoperative core needle biopsy specimens.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par13">We used Chi-square tests to compare the differences in clinicopathological characteristics and treatment information between the SERM/AI(SERM or AI)+OFS group and the SERM alone group. Kaplan-Meier curves and the log-rank test were utilized for survival analysis. Univariate and multivariate Cox regression analyses were performed to identify significant prognostic factors. Multivariable logistic regression model was used to predict the utilization of OFS. All analyses were perform using R version 4.2.3. <em>p</em> value &lt; 0.05 was considered statistically significant.</p></section></section><section id="Sec6"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec7"><h3 class="pmc_sec_title">Patients and characteristics</h3>
<p id="Par14">A total of 1,338 premenopausal women with HR+/HER2 + early-stage BC who received trastuzumab-based anti-HER2 treatment were enrolled in the study. The characteristics of these patients are summarized in Table <a href="#Tab1" class="usa-link">1</a>. 56.8%(760/1338)of patients received SERM alone as endocrine therapy. 570 patients received SERM/AI + OFS treatment, with the majority receiving AI + OFS (481/570) treatment. In the subgroup of those less than 35 years old, histologic grade 3, higher N stage (N1, N2&amp;N3) and ER expression levels below 50%, more patients receive SERM/AI plus OFS as adjuvant endocrine treatment. In addition, 22.12% of patients received both trastuzumab and pertuzumab as anti-HER2 treatment. Among these patients, a higher proportion received SERM/AI plus OFS compared to those receiving SERM alone (36.14% vs. 11.72%).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Patients’ characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variables</th>
<th align="left" colspan="1" rowspan="1">Total (<em>N</em> = 1338)</th>
<th align="left" colspan="1" rowspan="1">SERM (<em>N</em> = 768)</th>
<th align="left" colspan="1" rowspan="1">SERM/AI + OFS (<em>N</em> = 570)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;35</td>
<td align="left" colspan="1" rowspan="1">151 (11.29)</td>
<td align="left" colspan="1" rowspan="1">48 (6.25)</td>
<td align="left" colspan="1" rowspan="1">103 (18.07)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥ 35</td>
<td align="left" colspan="1" rowspan="1">1187 (88.71)</td>
<td align="left" colspan="1" rowspan="1">720 (93.75)</td>
<td align="left" colspan="1" rowspan="1">467 (81.93)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;50%</td>
<td align="left" colspan="1" rowspan="1">1096 (81.91)</td>
<td align="left" colspan="1" rowspan="1">593 (77.21)</td>
<td align="left" colspan="1" rowspan="1">503 (88.25)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥50%</td>
<td align="left" colspan="1" rowspan="1">242 (18.09)</td>
<td align="left" colspan="1" rowspan="1">175 (22.79)</td>
<td align="left" colspan="1" rowspan="1">67 (11.75)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PR, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.912</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;50%</td>
<td align="left" colspan="1" rowspan="1">669 (50.00)</td>
<td align="left" colspan="1" rowspan="1">385 (50.13)</td>
<td align="left" colspan="1" rowspan="1">284 (49.82)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥ 50%</td>
<td align="left" colspan="1" rowspan="1">669 (50.00)</td>
<td align="left" colspan="1" rowspan="1">383 (49.87)</td>
<td align="left" colspan="1" rowspan="1">286 (50.18)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ki67, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.687</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;30%</td>
<td align="left" colspan="1" rowspan="1">414 (30.94)</td>
<td align="left" colspan="1" rowspan="1">241 (31.38)</td>
<td align="left" colspan="1" rowspan="1">173 (30.35)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥ 30%</td>
<td align="left" colspan="1" rowspan="1">924 (69.06)</td>
<td align="left" colspan="1" rowspan="1">527 (68.62)</td>
<td align="left" colspan="1" rowspan="1">397 (69.65)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LVI, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>0.041</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="left" colspan="1" rowspan="1">1152 (86.10)</td>
<td align="left" colspan="1" rowspan="1">674 (87.76)</td>
<td align="left" colspan="1" rowspan="1">478 (83.86)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="left" colspan="1" rowspan="1">186 (13.90)</td>
<td align="left" colspan="1" rowspan="1">94 (12.24)</td>
<td align="left" colspan="1" rowspan="1">92 (16.14)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Grade, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> I-II</td>
<td align="left" colspan="1" rowspan="1">774 (57.85)</td>
<td align="left" colspan="1" rowspan="1">484 (63.02)</td>
<td align="left" colspan="1" rowspan="1">290 (50.88)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">564 (42.15)</td>
<td align="left" colspan="1" rowspan="1">284 (36.98)</td>
<td align="left" colspan="1" rowspan="1">280 (49.12)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tumor size, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.193</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤ 2 cm</td>
<td align="left" colspan="1" rowspan="1">713 (53.29)</td>
<td align="left" colspan="1" rowspan="1">421 (54.82)</td>
<td align="left" colspan="1" rowspan="1">292 (51.23)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt;2 cm</td>
<td align="left" colspan="1" rowspan="1">625 (46.71)</td>
<td align="left" colspan="1" rowspan="1">347 (45.18)</td>
<td align="left" colspan="1" rowspan="1">278 (48.77)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N Stage, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N0</td>
<td align="left" colspan="1" rowspan="1">772 (57.70)</td>
<td align="left" colspan="1" rowspan="1">500 (65.10)</td>
<td align="left" colspan="1" rowspan="1">272 (47.72)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N1</td>
<td align="left" colspan="1" rowspan="1">361 (26.98)</td>
<td align="left" colspan="1" rowspan="1">177 (23.05)</td>
<td align="left" colspan="1" rowspan="1">184 (32.28)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N2&amp;3</td>
<td align="left" colspan="1" rowspan="1">205 (15.32)</td>
<td align="left" colspan="1" rowspan="1">91 (11.85)</td>
<td align="left" colspan="1" rowspan="1">114 (20.00)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Surgery</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.448</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Breast conservation</td>
<td align="left" colspan="1" rowspan="1">378(28.4)</td>
<td align="left" colspan="1" rowspan="1">224 (29.20)</td>
<td align="left" colspan="1" rowspan="1">154 (27.30)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mastectomy</td>
<td align="left" colspan="1" rowspan="1">953(71.6)</td>
<td align="left" colspan="1" rowspan="1">543(70.8)</td>
<td align="left" colspan="1" rowspan="1">410(72.7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Chemotherapy, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Adjuvant</td>
<td align="left" colspan="1" rowspan="1">154 (11.51)</td>
<td align="left" colspan="1" rowspan="1">52 (6.77)</td>
<td align="left" colspan="1" rowspan="1">102 (17.89)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Neoadjuvant</td>
<td align="left" colspan="1" rowspan="1">1184 (88.49)</td>
<td align="left" colspan="1" rowspan="1">716 (93.23)</td>
<td align="left" colspan="1" rowspan="1">468 (82.11)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Radiotherapy, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No</td>
<td align="left" colspan="1" rowspan="1">508 (37.97)</td>
<td align="left" colspan="1" rowspan="1">343 (44.66)</td>
<td align="left" colspan="1" rowspan="1">165 (28.95)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Yes</td>
<td align="left" colspan="1" rowspan="1">830 (62.03)</td>
<td align="left" colspan="1" rowspan="1">425 (55.34)</td>
<td align="left" colspan="1" rowspan="1">405 (71.05)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-HER2 therapy, <em>N</em> (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> T</td>
<td align="left" colspan="1" rowspan="1">1042 (77.88)</td>
<td align="left" colspan="1" rowspan="1">678 (88.28)</td>
<td align="left" colspan="1" rowspan="1">364 (63.86)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> T + P</td>
<td align="left" colspan="1" rowspan="1">296 (22.12)</td>
<td align="left" colspan="1" rowspan="1">90 (11.72)</td>
<td align="left" colspan="1" rowspan="1">206 (36.14)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p17"><p><em>Abbreviations</em>: <em>SERM</em> selective estrogen receptor modulators, <em>AI</em> aromatase inhibitor, <em>OFS</em> ovarian function suppression, <em>LVI</em> lymphovascular invasion, <em>T</em> Trastuzumab, <em>P</em> Pertuzumab</p></div></div></section></section><section id="Sec8"><h3 class="pmc_sec_title">Survival analysis</h3>
<p id="Par16">
The median follow-up time was 46 months. Patients with HR+/HER2 + breast cancer who received SERM/AI plus OFS as adjuvant endocrine therapy showed significantly better DFS compared to those receiving SERM alone (HR = 0.496; 95% CI: 0.307–0.803; <em>p</em> = 0.004) (Fig. <a href="#Fig1" class="usa-link">1</a>). Subgroup analysis revealed that the OFS beneficiary population was predominantly those with tumors larger than 2 cm (Fig. <a href="#Fig2" class="usa-link">2</a>A), positive lymph nodes (Fig. <a href="#Fig2" class="usa-link">2</a>B), grade 3 (Fig. <a href="#Fig2" class="usa-link">2</a>C) and ER expression less than 50% (Fig. <a href="#Fig2" class="usa-link">2</a>D). In addition, univariate and multivariate Cox regression showed that endocrine therapy, age, lymphovascular invasion (LVI), lymph node status, and ER expression level were independent prognostic factors affecting DFS in HR+/HER2 + early-stage premenopausal breast cancer patients treated with trastuzumab (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12359915_12885_2025_14774_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa2/12359915/17a2b1b96022/12885_2025_14774_Fig1_HTML.jpg" loading="lazy" id="d33e815" height="456" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier estimate of disease-free survival for patients in SERM/AI + OFS versus SEEM alone group. SERM, selective estrogen receptor modulators; AI, aromatase inhibitor; OFS, ovarian function suppression; HR, hazard ratio; CI, confidence interval; ET, endocrine therapy</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12359915_12885_2025_14774_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa2/12359915/7228c33016dd/12885_2025_14774_Fig2_HTML.jpg" loading="lazy" id="d33e838" height="418" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan–Meier curves between SERM/AI + OFS and SEEM alone group in different cohorts. (<strong>A</strong>) Tumor size&gt;2 cm; (<strong>B</strong>) pN+; (<strong>C</strong>) Grade 3; (<strong>D</strong>) ER expression ≤ 50%</p></figcaption></figure><section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Univariate and multivariate Cox regression analyses</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Variables</th>
<th align="left" colspan="2" rowspan="1">Univariate</th>
<th align="left" colspan="2" rowspan="1">Multivariable</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">HR (95%CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
<th align="left" colspan="1" rowspan="1">HR (95%CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr>
</thead>
<tbody>
<tr><td align="left" colspan="5" rowspan="1">Endocrine therapy</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">SERM</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SERM/AI + OFS</td>
<td align="left" colspan="1" rowspan="1">0.50 (0.31 ~ 0.80)</td>
<td align="left" colspan="1" rowspan="1">0.004</td>
<td align="left" colspan="1" rowspan="1">0.41 (0.25 ~ 0.68)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Age</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥35</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;35</td>
<td align="left" colspan="1" rowspan="1">1.72 (0.99 ~ 3.00)</td>
<td align="left" colspan="1" rowspan="1">0.054</td>
<td align="left" colspan="1" rowspan="1">2.11 (1.19 ~ 3.74)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.01</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Grade</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1–2</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 3</td>
<td align="left" colspan="1" rowspan="1">2.05 (1.35 ~ 3.12)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">1.48 (0.91 ~ 2.42)</td>
<td align="left" colspan="1" rowspan="1">0.117</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">LVI</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Negative</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Positive</td>
<td align="left" colspan="1" rowspan="1">0.51 (0.24 ~ 1.10)</td>
<td align="left" colspan="1" rowspan="1">0.088</td>
<td align="left" colspan="1" rowspan="1">0.41 (0.19 ~ 0.89)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.024</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Node status</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> pN0</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> pN+</td>
<td align="left" colspan="1" rowspan="1">2.71 (1.76 ~ 4.18)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">2.50 (1.55 ~ 4.05)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Tumor size (cm)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤2</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt;2</td>
<td align="left" colspan="1" rowspan="1">1.89 (1.24 ~ 2.88)</td>
<td align="left" colspan="1" rowspan="1">0.003</td>
<td align="left" colspan="1" rowspan="1">1.37 (0.87 ~ 2.16)</td>
<td align="left" colspan="1" rowspan="1">0.175</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">ER expression</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &gt;50%</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≤ 50%</td>
<td align="left" colspan="1" rowspan="1">2.38 (1.55 ~ 3.64)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">1.88 (1.22 ~ 2.91)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.004</strong>
</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Ki67 (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> &lt;30%</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
<td align="left" colspan="2" rowspan="1">Ref</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> ≥30%</td>
<td align="left" colspan="1" rowspan="1">1.14 (0.72 ~ 1.80)</td>
<td align="left" colspan="1" rowspan="1">0.571</td>
<td align="left" colspan="1" rowspan="1">0.95 (0.58 ~ 1.55)</td>
<td align="left" colspan="1" rowspan="1">0.849</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p25"><p><em>Abbreviations</em>: <em>SERM</em> selective estrogen receptor modulators, <em>AI</em> aromatase inhibitor, <em>OFS</em> ovarian function suppression, <em>LVI</em> lymphovascular invasion, <em>HR</em> Hazard Ratio, <em>CI</em> Confidence Interval</p></div></div></section></section><section id="Sec9"><h3 class="pmc_sec_title">Predictors of OFS application</h3>
<p id="Par20">Age less than 35 years was the most influential factor in predicting OFS application (Odds Ratio 3.5, 95% CI 2.41, 5.09, <em>p</em> &lt; 0.001) (Table <a href="#Tab3" class="usa-link">3</a>). Patients with nodal involvement were more likely to receive OFS compared with those nodal negative (Odds Ratio 1.93, 95% CI 1.5, 2.49, <em>p</em> &lt; 0.001) (Table <a href="#Tab3" class="usa-link">3</a>). In addition, grade 3 was also an important factor in predicting OFS application (Odds Ratio 1.41, 95% CI 1.07, 1.86, <em>p</em> &lt; 0.001) (Table <a href="#Tab3" class="usa-link">3</a>). In contrast to ER expression above 50%, patients with ER expression below 50% were less likely to receive OFS (<em>p</em> &lt; 0.001) (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Multivariable logistic regression model of clinicopathologic characteristics to determine the efficacy of OFS</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Clinicopathologic variable</th>
<th align="left" colspan="1" rowspan="1">OR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age: &lt;35 years vs. ≥ 35 years</td>
<td align="left" colspan="1" rowspan="1">3.50 (2.41 ~ 5.09)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tumor size: ≤2 cm vs. &gt;2 cm</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.73 ~ 1.19)</td>
<td align="left" colspan="1" rowspan="1">0.58</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N stage: ≥N1 vs. N0</td>
<td align="left" colspan="1" rowspan="1">1.93 (1.50 ~ 2.49)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LVI: Positive vs. Negative</td>
<td align="left" colspan="1" rowspan="1">1.22 (0.87 ~ 1.69)</td>
<td align="left" colspan="1" rowspan="1">0.246</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Grade: 3 vs. 1 and 2</td>
<td align="left" colspan="1" rowspan="1">1.41 (1.07 ~ 1.86)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.015</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ER expression: &lt;50% vs. ≥ 50%</td>
<td align="left" colspan="1" rowspan="1">0.39 (0.28 ~ 0.54)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ki67 index: &lt;30% vs. ≥ 30%</td>
<td align="left" colspan="1" rowspan="1">0.93 (0.71 ~ 1.22)</td>
<td align="left" colspan="1" rowspan="1">0.606</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p29"><p><em>Abbreviations</em>: <em>OFS</em> ovarian function suppression, <em>LVI</em> lymphovascular invasion, <em>OR</em> Odds Ratio, <em>CI</em> Confidence Interval</p></div></div></section></section></section><section id="Sec10"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par22">According to the St. Gallen 2021 expert consensus, 94% of experts agree that premenopausal patients with ER-positive, HER2-negative breast cancer who are at high enough risk to warrant chemotherapy should also receive OFS if they remain premenopausal after chemotherapy treatment [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. However, there is no consensus regarding OFS for HR+/HER2 + BC due to insufficient evidence. In our study, we included 1,338 premenopausal patients with HR+/HER2 + early-stage BC who were treated with trastuzumab-based anti-HER2 therapy and endocrine therapy. We found that patients receiving SERM/AI plus OFS had significantly better DFS compared to those receiving SERM alone.</p>
<p id="Par23">In the SOFT trial, which enrolled 3,047 premenopausal women with HR + breast cancer, 367 (12%) patients had HR+/HER2 + disease. After 12 years of follow-up, the results indicated that HER2-positive tumors benefited more from the addition of OFS compared to HER2-negative tumors [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. However, only 54% of patients with HER2 + disease in the combined SOFT and TEXT population received anti-HER2 therapy, which is now recommended for nearly all patients with HER2 + breast cancer [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The results of these clinical trials cannot tell us whether patients still benefit from OFS after receiving standard chemotherapy and anti-HER2 therapy. This study provides new evidence to address this confusion. After univariate and multivariate Cox regression analysis, we confirmed that receiving SERM/AI plus OFS as adjuvant endocrine therapy was an independent prognostic factor for premenopausal patients with HR+/HER2 + early-stage BC who were treated with trastuzumab-based anti-HER2 therapy. A retrospective study by Ju et al. has reported similar results [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. However, the ASTRRA trial reported contrasting results [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Unlike the SOFT trial, the ASTRRA trial included a younger population with a higher risk of recurrence and administered only 2 years of OFS. This shorter duration may not effectively cover the peak period of recurrence for HR+/HER2 + BC, which could explain why patients in the ASTRRA trial did not benefit from OFS.</p>
<p id="Par24">Furthermore, the use of OFS for HR+/HER2 + BC varies across different countries. A study from the United States founded that only 12.7% of patients with HR+/HER2 + BC received OFS [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Among these patients, age was the only clinicopathologic feature associated with OFS use, with those under 35 years old being more likely to receive OFS compared to those aged 35 and older. Young age is considered an independent risk factor for breast cancer prognosis [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The SOFT trial demonstrated that premenopausal HR + breast cancer patients under 35 years old benefit from OFS. OFS is recommended for HR+/HER2- premenopausal breast cancer patients younger than 35 years. In our study, we reported similar result. A higher proportion of younger patients (&lt;35 years) with HR+/HER2 + BC received SERM/AI plus OFS as adjuvant endocrine therapy.</p>
<p id="Par25">ER expression levels below 50% were identified as important prognostic factors for HR+/HER2 + breast cancer (Table <a href="#Tab2" class="usa-link">2</a>). Our findings suggest that patients with ER expression below 50% may derive greater benefit from the addition of OFS. Furthermore, tumor size larger than 2 cm, lymph node-positive, and Grade 3 tumors were also associated with the recommendation for OFS according to our results. A study by Ju et al. indicated that the benefits of OFS in patients with HR+/HER2 + breast cancer were limited to those with lymph node-positive disease [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. This may be attributed to the small sample size of the study, which predominantly included lymph node-positive patients.</p>
<p id="Par26">To our knowledge, this is the largest Chinese cohort to date exploring the value of OFS in HR+/HER2 + early-stage breast cancer. However, this study has several limitations. As a retrospective real-world study, it is subject to follow-up bias, selection bias, and confounding factors. Moreover, information on pathologic complete response (pCR) following neoadjuvant chemotherapy(NAC) was unavailable, preventing us from evaluating its influence on OFS decisions or disease-free survival. Secondly, we did not investigate the optimal partner for OFS (TAM or AI) for high-risk premenopausal patients with HR+/HER2 + BC. Thirdly, due to unavailability of data regarding the specific timing of endocrine therapy and the proportion of cases with amenorrhea due to chemotherapy, we are unable to correct for this confounding factor. Finally, further research with larger sample sizes and longer follow-up is needed to confirm the effects of OFS for premenopausal patients with HR+/HER2 + BC.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par27">In summary, premenopausal patients with HR+/HER2 + early-stage BC could benefit from the additional OFS after trastuzumab treatment. Age&lt;35 years, nodal involvement, histological grade 3 or ER expression below 50% were the predictor of OFS application.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We appreciate the data support provided by the Shanghai Jiaotong University-Breast cancer Database (SJTU-BCDB) (<a href="http://47.100.125.104:8080/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://47.100.125.104:8080/</a>).</p></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>WL, CH and DC contributed to the study conception and design, analysis of data was contributed by WL and LL, WL and LL prepared all the figures and tables, WL drafted the manuscript, WL, CH and DC discussed and edited the paper. All authors read and approved the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the Quanzhou City Science &amp; Technology Program of China (Grant No.2021N076S).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The data supporting all tables and figures in this published article are not publicly available to protect patient privacy but can be accessed from the corresponding author on request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par28">The study protocol received approval from the independent ethical committee of Quanzhou First Hospital, affiliated with Fujian Medical University, and adhered to the principles of the Helsinki Declaration. A waiver of informed consent was granted due to the retrospective nature of the study.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par29">Not applicable.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par30">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Weibin Lian, Email: weibinlian@fjmu.edu.cn.</p>
<p>Chengye Hong, Email: hongcy01@fjmu.edu.cn.</p>
<p>Debo Chen, Email: debochensr@fjmu.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Fan L, Strasser-Weippl K, Li JJ, St LJ, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE. Breast cancer in China. Lancet Oncol. 2014;15(7):e279–89.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(13)70567-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24872111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fan%20L,%20Strasser-Weippl%20K,%20Li%20JJ,%20St%20LJ,%20Finkelstein%20DM,%20Yu%20KD,%20Chen%20WQ,%20Shao%20ZM,%20Goss%20PE.%20Breast%20cancer%20in%20China.%20Lancet%20Oncol.%202014;15(7):e279%E2%80%9389." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Dodson A, Parry S, Ibrahim M, Bartlett JM, Pinder S, Dowsett M, Miller K. Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients. The Journal of Pathology: Clinical Research. 2018;4(4):262–73.
</cite> [<a href="https://doi.org/10.1002/cjp2.112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6174620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30066480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dodson%20A,%20Parry%20S,%20Ibrahim%20M,%20Bartlett%20JM,%20Pinder%20S,%20Dowsett%20M,%20Miller%20K.%20Breast%20cancer%20biomarkers%20in%20clinical%20testing:%20analysis%20of%20a%20UK%20national%20external%20quality%20assessment%20scheme%20for%20immunocytochemistry%20and%20in%20situ%20hybridisation%20database%20containing%20results%20from%20199%20300%20patients.%20The%20Journal%20of%20Pathology:%20Clinical%20Research.%202018;4(4):262%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Rowden D, Solky AJ, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update. J Clin Oncol. 2014;32(21):2255–69.
</cite> [<a href="https://doi.org/10.1200/JCO.2013.54.2258" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4876310/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24868023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burstein%20HJ,%20Temin%20S,%20Anderson%20H,%20Buchholz%20TA,%20Davidson%20NE,%20Gelmon%20KE,%20Giordano%20SH,%20Hudis%20CA,%20Rowden%20D,%20Solky%20AJ,%20et%20al.%20Adjuvant%20endocrine%20therapy%20for%20women%20with%20hormone%20receptor-positive%20breast%20cancer:%20American%20society%20of%20clinical%20oncology%20clinical%20practice%20guideline%20focused%20update.%20J%20Clin%20Oncol.%202014;32(21):2255%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Francis PA, Regan MM, Fleming GF, Lang I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da PG, Burstein HJ, et al. Adjuvant ovarian suppression in premenopausal breast cancer. New Engl J Med. 2015;372(5):436–46.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1412379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4341825/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25495490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Francis%20PA,%20Regan%20MM,%20Fleming%20GF,%20Lang%20I,%20Ciruelos%20E,%20Bellet%20M,%20Bonnefoi%20HR,%20Climent%20MA,%20Da%20PG,%20Burstein%20HJ,%20et%20al.%20Adjuvant%20ovarian%20suppression%20in%20premenopausal%20breast%20cancer.%20New%20Engl%20J%20Med.%202015;372(5):436%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Francis PA, Fleming GF, Lang I, Ciruelos EM, Bonnefoi HR, Bellet M, Bernardo A, Climent MA, Martino S, Bermejo B, et al. Adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from SOFT. J Clin Oncol. 2023;41(7):1370–5.
</cite> [<a href="https://doi.org/10.1200/JCO.22.01065" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10419521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36493334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Francis%20PA,%20Fleming%20GF,%20Lang%20I,%20Ciruelos%20EM,%20Bonnefoi%20HR,%20Bellet%20M,%20Bernardo%20A,%20Climent%20MA,%20Martino%20S,%20Bermejo%20B,%20et%20al.%20Adjuvant%20endocrine%20therapy%20in%20premenopausal%20breast%20cancer:%2012-year%20results%20from%20SOFT.%20J%20Clin%20Oncol.%202023;41(7):1370%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Kim HA, Lee JW, Nam SJ, Park BW, Im SA, Lee ES, Jung YS, Yoon JH, Kang SS, Lee SJ, et al. Adding ovarian suppression to Tamoxifen for premenopausal breast cancer: a randomized phase III trial. J Clin Oncol. 2020;38(5):434–43.
</cite> [<a href="https://doi.org/10.1200/JCO.19.00126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31518174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20HA,%20Lee%20JW,%20Nam%20SJ,%20Park%20BW,%20Im%20SA,%20Lee%20ES,%20Jung%20YS,%20Yoon%20JH,%20Kang%20SS,%20Lee%20SJ,%20et%20al.%20Adding%20ovarian%20suppression%20to%20Tamoxifen%20for%20premenopausal%20breast%20cancer:%20a%20randomized%20phase%20III%20trial.%20J%20Clin%20Oncol.%202020;38(5):434%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Johnston S, Toi M, O’Shaughnessy J, Rastogi P, Campone M, Neven P, Huang CS, Huober J, Jaliffe GG, Cicin I, et al. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a Preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023;24(1):77–90.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(22)00694-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11200328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36493792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnston%20S,%20Toi%20M,%20O%E2%80%99Shaughnessy%20J,%20Rastogi%20P,%20Campone%20M,%20Neven%20P,%20Huang%20CS,%20Huober%20J,%20Jaliffe%20GG,%20Cicin%20I,%20et%20al.%20Abemaciclib%20plus%20endocrine%20therapy%20for%20hormone%20receptor-positive,%20HER2-negative,%20node-positive,%20high-risk%20early%20breast%20cancer%20(monarchE):%20results%20from%20a%20Preplanned%20interim%20analysis%20of%20a%20randomised,%20open-label,%20phase%203%20trial.%20Lancet%20Oncol.%202023;24(1):77%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Alataki A, Dowsett M. Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer. Endocr-relat Cancer. 2022;29(8):R105–22.
</cite> [<a href="https://doi.org/10.1530/ERC-21-0293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9254309/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35613334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alataki%20A,%20Dowsett%20M.%20Human%20epidermal%20growth%20factor%20receptor-2%20and%20endocrine%20resistance%20in%20hormone-dependent%20breast%20cancer.%20Endocr-relat%20Cancer.%202022;29(8):R105%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Dowsett M, Johnston S, Martin LA, Salter J, Hills M, Detre S, Gutierrez MC, Mohsin SK, Shou J, Allred DC, et al. Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience. Endocr-relat Cancer. 2005;12(Suppl 1):S113-7.
</cite> [<a href="https://doi.org/10.1677/erc.1.01044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16113087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dowsett%20M,%20Johnston%20S,%20Martin%20LA,%20Salter%20J,%20Hills%20M,%20Detre%20S,%20Gutierrez%20MC,%20Mohsin%20SK,%20Shou%20J,%20Allred%20DC,%20et%20al.%20Growth%20factor%20signalling%20and%20response%20to%20endocrine%20therapy:%20the%20Royal%20Marsden%20Experience.%20Endocr-relat%20Cancer.%202005;12(Suppl%201):S113-7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Rasmussen BB, Regan MM, Lykkesfeldt AE, Dell’Orto P, Del CB, Henriksen KL, Mastropasqua MG, Price KN, Mery E, Lacroix-Triki M, et al. Adjuvant letrozole versus Tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1–98 randomised trial. Lancet Oncol. 2008;9(1):23–8.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(07)70386-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18083065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rasmussen%20BB,%20Regan%20MM,%20Lykkesfeldt%20AE,%20Dell%E2%80%99Orto%20P,%20Del%20CB,%20Henriksen%20KL,%20Mastropasqua%20MG,%20Price%20KN,%20Mery%20E,%20Lacroix-Triki%20M,%20et%20al.%20Adjuvant%20letrozole%20versus%20Tamoxifen%20according%20to%20centrally-assessed%20ERBB2%20status%20for%20postmenopausal%20women%20with%20endocrine-responsive%20early%20breast%20cancer:%20supplementary%20results%20from%20the%20BIG%201%E2%80%9398%20randomised%20trial.%20Lancet%20Oncol.%202008;9(1):23%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, et al. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer. N Engl J Med. 2017;377(2):122–31.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1703643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5538020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28581356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?von%20Minckwitz%20G,%20Procter%20M,%20de%20Azambuja%20E,%20Zardavas%20D,%20Benyunes%20M,%20Viale%20G,%20Suter%20T,%20Arahmani%20A,%20Rouchet%20N,%20Clark%20E,%20et%20al.%20Adjuvant%20pertuzumab%20and%20trastuzumab%20in%20early%20HER2-positive%20breast%20cancer.%20N%20Engl%20J%20Med.%202017;377(2):122%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Cameron D, Piccart-Gebhart MJ, Gelber RD, Procter M, Goldhirsch A, de Azambuja E, Castro GJ, Untch M, Smith I, Gianni L, et al. 11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin adjuvant (HERA) trial. Lancet. 2017;389(10075):1195–205.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)32616-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5465633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28215665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cameron%20D,%20Piccart-Gebhart%20MJ,%20Gelber%20RD,%20Procter%20M,%20Goldhirsch%20A,%20de%20Azambuja%20E,%20Castro%20GJ,%20Untch%20M,%20Smith%20I,%20Gianni%20L,%20et%20al.%2011%20years%E2%80%99%20follow-up%20of%20trastuzumab%20after%20adjuvant%20chemotherapy%20in%20HER2-positive%20early%20breast%20cancer:%20final%20analysis%20of%20the%20HERceptin%20adjuvant%20(HERA)%20trial.%20Lancet.%202017;389(10075):1195%E2%80%93205." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Regan MM, Francis PA, Pagani O, Fleming GF, Walley BA, Viale G, Colleoni M, Lang I, Gomez HL, Tondini C, et al. Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: TEXT and SOFT trials. J Clin Oncol. 2016;34(19):2221–31.
</cite> [<a href="https://doi.org/10.1200/JCO.2015.64.3171" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4962708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27044936/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Regan%20MM,%20Francis%20PA,%20Pagani%20O,%20Fleming%20GF,%20Walley%20BA,%20Viale%20G,%20Colleoni%20M,%20Lang%20I,%20Gomez%20HL,%20Tondini%20C,%20et%20al.%20Absolute%20benefit%20of%20adjuvant%20endocrine%20therapies%20for%20premenopausal%20women%20with%20hormone%20receptor-positive,%20human%20epidermal%20growth%20factor%20receptor%202-negative%20early%20breast%20cancer:%20TEXT%20and%20SOFT%20trials.%20J%20Clin%20Oncol.%202016;34(19):2221%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Thomssen C, Balic M, Harbeck N, Gnant M. St. Gallen/Vienna. 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer. Breast Care. 2021;16(2):135–43.
</cite> [<a href="https://doi.org/10.1159/000516114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8089428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34002112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thomssen%20C,%20Balic%20M,%20Harbeck%20N,%20Gnant%20M.%20St.%20Gallen/Vienna.%202021:%20A%20Brief%20Summary%20of%20the%20Consensus%20Discussion%20on%20Customizing%20Therapies%20for%20Women%20with%20Early%20Breast%20Cancer.%20Breast%20Care.%202021;16(2):135%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Lang I, Gomez HL, Tondini C, Ciruelos E, Burstein HJ, et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. 2018;379(2):122–37.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1803164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6193457/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29863451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Francis%20PA,%20Pagani%20O,%20Fleming%20GF,%20Walley%20BA,%20Colleoni%20M,%20Lang%20I,%20Gomez%20HL,%20Tondini%20C,%20Ciruelos%20E,%20Burstein%20HJ,%20et%20al.%20Tailoring%20adjuvant%20endocrine%20therapy%20for%20premenopausal%20breast%20cancer.%20N%20Engl%20J%20Med.%202018;379(2):122%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Ju J, Gao SL, Wang JY, Sang D, Kang YK, Wang X, Yue J, Shuai Y, Qi YX, Yuan P. Prognostic factors and benefit populations of ovarian function suppression in premenopausal HR+/HER2 + early-stage breast cancer patients who received trastuzumab: evidence from a real-world study with long-term follow-up. Thorac Cancer. 2024;15(6):439–47.
</cite> [<a href="https://doi.org/10.1111/1759-7714.15211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10883855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38185807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ju%20J,%20Gao%20SL,%20Wang%20JY,%20Sang%20D,%20Kang%20YK,%20Wang%20X,%20Yue%20J,%20Shuai%20Y,%20Qi%20YX,%20Yuan%20P.%20Prognostic%20factors%20and%20benefit%20populations%20of%20ovarian%20function%20suppression%20in%20premenopausal%20HR+/HER2%E2%80%89+%E2%80%89early-stage%20breast%20cancer%20patients%20who%20received%20trastuzumab:%20evidence%20from%20a%20real-world%20study%20with%20long-term%20follow-up.%20Thorac%20Cancer.%202024;15(6):439%E2%80%9347." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Sukumar JS, Sardesai S, Ni A, Williams N, Johnson K, Quiroga D, Ramaswamy B, Wesolowski R, Cherian M, Stover DG, et al. Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2 + breast cancer. Cancer Med. 2024;13(12): e7317.
</cite> [<a href="https://doi.org/10.1002/cam4.7317" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11185945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38895891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sukumar%20JS,%20Sardesai%20S,%20Ni%20A,%20Williams%20N,%20Johnson%20K,%20Quiroga%20D,%20Ramaswamy%20B,%20Wesolowski%20R,%20Cherian%20M,%20Stover%20DG,%20et%20al.%20Real-world%20treatment%20patterns%20of%20adjuvant%20endocrine%20therapy%20and%20ovarian%20suppression%20in%20premenopausal%20HR+/HER2%E2%80%89+%E2%80%89breast%20cancer.%20Cancer%20Med.%202024;13(12):%20e7317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P, Zeng B, Huang M, Wang C. The impact of young age for prognosis by subtype in women with early breast cancer. Sci Rep. 2017;7(1): 11625.
</cite> [<a href="https://doi.org/10.1038/s41598-017-10414-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28912475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lian%20W,%20Fu%20F,%20Lin%20Y,%20Lu%20M,%20Chen%20B,%20Yang%20P,%20Zeng%20B,%20Huang%20M,%20Wang%20C.%20The%20impact%20of%20young%20age%20for%20prognosis%20by%20subtype%20in%20women%20with%20early%20breast%20cancer.%20Sci%20Rep.%202017;7(1):%2011625." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data supporting all tables and figures in this published article are not publicly available to protect patient privacy but can be accessed from the corresponding author on request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Cancer are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12885-025-14774-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12885_2025_Article_14774.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12359915/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12359915/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12359915%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12359915/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12359915/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12359915/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40826347/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12359915/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40826347/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12359915/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12359915/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="R554A7g9FtMjjGNBkgn8fH3uJ6jfqoj6GaMMqBLaM7iaXQsu1MiPrn6b4mpHhsJ5">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
